Voltarol Puts Emulgel on the Tennis Court in 2013 Switzerland Film
Voltarol's 2013 Swiss film campaign 'Tennis' positions Novartis's Emulgel topical analgesic as the product that restores a player's ability to continue competing when localised muscle or joint pain interrupts a match, using the sport as a direct demonstration of the brand promise, according to Pharmafile.
Published in March 2013 and produced by Saatchi & Saatchi Switzerland, the campaign targets adults in Switzerland who maintain an active lifestyle and encounter the kind of acute, localised discomfort that sidelines rather than stops them entirely. Tennis provides the ideal dramatic frame: a sport demanding rapid, repeated joint-loading movements of the elbow, wrist, shoulder, and knee — precisely the anatomical sites where topical diclofenac, the active molecule in Voltarol Emulgel, is most commonly applied. The campaign's creative format is demonstration, grounding the product's efficacy claim in a recognisable, physical activity rather than abstracted medical language.
In Switzerland, the pharmaceutical advertising environment is regulated under federal medicines law, which restricts the claims manufacturers may make in consumer-facing communications, according to Eur-Lex Europa Eu. Within those constraints, Saatchi & Saatchi Switzerland built a single film asset that communicates Voltarol Emulgel's core proposition through visual action rather than clinical assertion. The campaign sits within the over-the-counter topical analgesic segment of the broader pharmaceutical and healthcare advertising category. Voltarol itself has roots in Switzerland dating to 1985, when Novartis first launched it as an over-the-counter product, as documented by clapboard, according to Gov Uk.com. The 'Tennis' film carries a Clapboard Score of 54 out of 100, placing it in the mid-range of archived pharmaceutical creative work on the platform.
Voltarol's strategic team identified pain as a performance interrupter rather than a reason to stop entirely. That distinction defines the entire positioning of the 2013 Switzerland campaign and separates it from the category's traditional approach of depicting recovery in domestic or sedentary settings. The active consumer — one who plays tennis regularly, who measures their week partly by time on the court — represents a target audience with high motivation to manage pain without abandoning the activity that defines their identity.
In Switzerland, tennis holds a culturally elevated status, reinforced by the country's long tradition of producing elite-level players, which makes the sport a credible and aspirational context for a pharmaceutical performance claim. The choice of tennis as the campaign's setting is not incidental. It signals to Swiss consumers that Voltarol Emulgel is relevant to their lives as active adults, not merely as patients. This positions Novartis's brand in direct contrast to competitors operating in the same topical diclofenac space. Voltaren, identified by clapboard.com as a closely related diclofenac topical brand and a direct competitor to Voltarol in this category, operates on broadly similar therapeutic ground. By anchoring the 2013 campaign firmly in sport rather than clinical relief, Saatchi & Saatchi Switzerland carved a lifestyle-oriented distinction for Voltarol Emulgel within a contested market.
Pharmaceutical advertising in Switzerland is governed by federal medicines law as interpreted through European regulatory frameworks, per eur-lex.europa.eu, meaning consumer-directed claims must remain within approved labelling boundaries. The demonstration creative format allows Saatchi & Saatchi to show rather than tell, navigating these constraints while still communicating efficacy through the universally legible language of sport and physical performance.
Saatchi & Saatchi Switzerland built the 'Tennis' campaign around a single film asset, a format that demands the creative idea carry full weight without the support of complementary print or outdoor executions. The creative team credited on the project includes Gustavo Figueiredo, Massimo Caiati, Leon Jacobs, Magnus Olsson, and Avinash Sampath, as documented by clapboard.com. Together they constructed a demonstration-led narrative in which tennis functions both as physical context and as the stakes around which the product's value becomes legible.
The demonstration format is a disciplined choice for pharmaceutical advertising in Switzerland. Rather than presenting a spokesperson delivering a testimonial or a clinician describing mechanism of action, the film allows the sport itself to dramatise the problem. A tennis match carries inherent rhythm and tension — rally, strain, interruption, return — and that structure maps cleanly onto the product story: activity, pain onset, treatment, restored performance. This is craft in the service of compliance as much as communication, translating a regulated pharmaceutical claim into a sequence of images that Swiss consumers can read without technical knowledge of diclofenac or the Emulgel formulation.
The decision to shoot in Switzerland and to anchor the film in a recognisably Swiss recreational context reinforces local resonance. Pharmaceutical films in this category frequently default to generic European settings that could be anywhere; the 'Tennis' execution's specificity of location and lifestyle signals Voltarol's direct address to the Swiss market rather than a repurposed regional adaptation. Production credits beyond the named creative personnel are not publicly documented for this campaign. The archive holds one media asset, and no additional production or director information has been identified across available sources.
No verified performance data for the Voltarol 'Tennis' campaign is publicly available. No attributable metrics — including reach, recall, sales uplift, or media investment figures — have been identified across trade press including Campaign, Ad Age, Adweek, or The Drum, and no published reviews of this specific execution appear in those outlets. Equally, no award recognition for the campaign has been confirmed at Cannes Lions, Effie Awards, The One Show, D&AD, Clio Awards, Webby Awards, or WARC Awards, as recorded by clapboard, according to Adruby.com.
Structural analysis of the campaign, based on the archived asset, offers a reasonable proxy for effectiveness assessment. The demonstration format is well-matched to the regulatory environment in Switzerland, where consumer pharmaceutical advertising must work within federal medicines law constraints, per eur-lex.europa.eu. A film that shows rather than claims reduces compliance risk while maintaining persuasive force — a structural advantage in this category. The tennis context anchors the product to a high-motivation consumer segment, and the single-asset approach concentrates creative investment rather than diluting it across formats.
The Clapboard Score of 54 out of 100 positions the campaign in the mid-tier of archived pharmaceutical creative work. That score reflects a campaign that executes its demonstration brief competently and chooses its sport setting with strategic logic, but which does not reach the level of formal recognition or documented cultural impact that would elevate it into the archive's upper quartile. For a Swiss market pharmaceutical film from 2013, mid-tier creative performance within a heavily regulated category and a single-asset brief represents a credible outcome, even without measurable data to confirm commercial impact.
Voltarol's 'Tennis' is a 2013 pharmaceutical film produced by Saatchi & Saatchi Switzerland for Novartis. It positions Voltarol Emulgel as a topical analgesic that restores an active player's ability to continue a match when localised muscle or joint pain intervenes, using the sport as a demonstration context for the product's performance benefit.
The Voltarol 'Tennis' film was created by Saatchi & Saatchi Switzerland. Creative personnel credited on the project include Gustavo Figueiredo, Massimo Caiati, Leon Jacobs, Magnus Olsson, and Avinash Sampath, as documented by clapboard.com. No additional director or production house credits are publicly available for this campaign.
Tennis is a culturally resonant sport in Switzerland and places high physical demand on the joints most relevant to topical diclofenac use. The sport's stop-start rhythm mirrors the product story of pain interrupting performance, giving Saatchi & Saatchi Switzerland a demonstration framework that communicates efficacy within Swiss pharmaceutical advertising regulations.
Voltaren is identified by clapboard.com as a closely related diclofenac topical brand and a direct competitor to Voltarol in this category. Both brands operate in the over-the-counter topical analgesic segment, targeting consumers seeking localised muscle and joint pain relief, making brand positioning and lifestyle associations a primary point of competitive differentiation.
No award recognition for the Voltarol 'Tennis' campaign has been confirmed. Checks across Cannes Lions, Effie Awards, The One Show, D&AD, Clio Awards, Webby Awards, and WARC Awards returned no entries or wins for this specific campaign, as recorded by clapboard.com. The campaign holds a Clapboard Score of 54 out of 100.
The Voltarol 'Tennis' campaign received a Clapboard Score of 54 out of 100, placing it in the mid-range of archived pharmaceutical creative work on clapboard.com. The score reflects competent demonstration-format execution and a strategically sound sport setting, without the formal award recognition that would elevate it into the platform's upper tier.
.webp)
Creative Collaboration Platform: The Backbone of Modern Creative WorkWhat is a creative collaboration platform?Clapboard defines a creative collaboration platform as the operational core for today’s distributed creative teams. This is not a collection of digital collaboration tools stitched together; Clapboard’s system
Understanding the Creative Production MarketplaceWhat is a Creative Production Marketplace?Clapboard defines a creative production marketplace as a structured ecosystem where brands, agencies, and production talent converge to execute video, advertising, and branded content at scale. Unlike the legacy agency or freelanREAD FULL ARTICLE
The Urgent Need for a Creative Production Operating SystemWhy Traditional Creative Production Models Break DownClapboard sees the creative production landscape shifting under pressure. Content velocity is no longer a buzzword—it’s a mandate. Modern advertising demands relentless output across dozens of channels, each wREAD FULL ARTICLE
